>Marché de la chirurgie du cancer du poumon en Asie-Pacifique, par type de produit ( instruments chirurgicaux , système de surveillance et de visualisation, équipement endochirurgical, systèmes de chirurgie thoracique assistée par robot et autres), procédure chirurgicale (thoracotomie et chirurgie mini-invasive ), type de patient (homme et femme), utilisateur final (hôpitaux, centres de chirurgie ambulatoire , laboratoires universitaires et de recherche, centres spécialisés de soins contre le cancer et autres), canal de distribution (appel d'offres direct, ventes au détail, ventes en ligne et autres) - Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et perspectives du marché de la chirurgie du cancer du poumon en Asie-Pacifique
La chirurgie en coin est une procédure utilisée pour retirer le cancer du poumon ainsi qu'une petite quantité de tissu sain. La résection segmentaire fait référence à l'ablation d'une plus grande partie des poumons. Une lobectomie est une procédure visant à retirer l'un des cinq lobes des poumons. La pneumonectomie est l'ablation chirurgicale de l'ensemble des poumons.
Le marché de la chirurgie du cancer du poumon en Asie-Pacifique devrait connaître une croissance significative au cours de la période de prévision de 2022 à 2029. Data Bridge Market Research analyse que le marché croît avec un TCAC de 6,0 % au cours de la période de prévision de 2022 à 2029 et devrait atteindre 1 368,70 millions USD d'ici 2029.
Rapport métrique |
Détails |
Période de prévision |
2022 à 2029 |
Année de base |
2021 |
Années historiques |
2020 (Personnalisable 2019-2014) |
Unités quantitatives |
Chiffre d'affaires en millions USD |
Segments couverts |
Par type de produit (instruments chirurgicaux, système de surveillance et de visualisation, équipement endochirurgical, systèmes de chirurgie thoracique assistée par robot et autres), procédure chirurgicale (thoracotomie et chirurgie mini-invasive), type de patient (homme et femme), utilisateur final (hôpitaux, centres de chirurgie ambulatoire, laboratoires universitaires et de recherche, centres spécialisés dans le traitement du cancer et autres), canal de distribution (appel d'offres direct, vente au détail, vente en ligne et autres) |
Pays couverts |
Chine, Japon, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Reste de l'Asie-Pacifique |
Acteurs du marché couverts |
Les principales entreprises présentes sur le marché sont Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology (Beijing) Co, Ltd., Intuitive Surgical, FusionKraft, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH entre autres. |
Définition du marché
Selon le type, la localisation et le stade du cancer du poumon, ainsi que d’autres problèmes médicaux, certaines personnes peuvent être candidates à une chirurgie du cancer du poumon. Ce type de chirurgie est utilisé pour traiter le cancer du poumon. Elle consiste à retirer la tumeur, une partie du tissu pulmonaire qui l’entoure et souvent aussi certains ganglions lymphatiques. Lorsque le cancer du poumon est limité et qu’on ne s’attend pas à ce qu’il se propage, la chirurgie pour retirer la tumeur est considérée comme la meilleure option. Cela inclut les tumeurs carcinoïdes et le cancer du poumon non à petites cellules à ses premiers stades.
Dynamique du marché de la chirurgie du cancer du poumon
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Increased Prevalence Of Lung Cancer Diseases
Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to Asia-Pacific health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.
-
Technological Advancement In The Field Of Healthcare
Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.
In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market
-
Increased Awareness Regarding The Benefits
The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.
The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the Asia-Pacific lung cancer surgery market.
Opportunities
-
Rise of Minimally Invasive Techniques in Lung Cancer Surgery
Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.
Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the Asia-Pacific lung cancer surgery market.
Restraints/Challenges
However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market
This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lung Cancer Surgery Market
All industries, including healthcare, medical device services, automotive, pharmaceutical and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lung cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lung cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion and population lockdown, all of which slow down referrals and patient flow.
The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lung cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number and vaccination against it is increasing across the Asia-Pacific.
Recent Development
- In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.
Asia-Pacific Lung Cancer Surgery Market Scope
Asia-Pacific lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user, and distribution channel. The growth amongst these segments will help you analyses meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
- Surgical Instruments
- Monitoring & Visualizing System
- Endosurgical Equipment
- Robotic-Assisted Thoracic Surgery Systems
- Others
On the basis of product type, the Asia-Pacific lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.
Surgical Procedure
- Thoracotomy
- Minimally Invasive Surgery
On the basis of surgical procedure, the Asia-Pacific lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.
Patient Type
- Male
- Female
On the basis of patient type, the Asia-Pacific lung cancer surgery market is segmented into male and female.
End User
- Hospitals
- Ambulatory & Surgical Centers
- Academic & Research Institutes
- Centre de soins spécialisés contre le cancer
- Autres
Sur la base de l'utilisateur final, le marché de la chirurgie du cancer du poumon en Asie-Pacifique est segmenté en hôpitaux, centres ambulatoires et chirurgicaux, instituts universitaires et de recherche, centres spécialisés dans les soins contre le cancer et autres.
Canal de distribution
- Appel d'offres direct
- Ventes au détail
- Ventes en ligne
- Autres
Sur la base du canal de distribution, le marché de la chirurgie du cancer du poumon en Asie-Pacifique est segmenté en appels d'offres directs, ventes au détail, ventes en ligne et autres.
Analyse/perspectives régionales du marché de la chirurgie du cancer du poumon
Le marché de la chirurgie du cancer du poumon est analysé et des informations et tendances sur la taille du marché sont fournies par pays, type de produit, procédure chirurgicale, type de patient, utilisateur final et canal de distribution comme référencé ci-dessus.
Le marché de la chirurgie du cancer du poumon en Asie-Pacifique comprend les pays suivants : Chine, Japon, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines et reste de l'Asie-Pacifique.
La Chine domine le marché de la chirurgie du cancer du poumon en Asie-Pacifique en termes de part de marché et de chiffre d'affaires et continuera de renforcer sa domination au cours de la période de prévision. Cela est dû au besoin croissant de vérification et de validation des processus chirurgicaux oncologiques dans le pays et au développement rapide de la recherche.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation, sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques d'Asie-Pacifique et les défis auxquels elles sont confrontées en raison de la forte concurrence des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché de la chirurgie du cancer du poumon
Le paysage concurrentiel du marché de la chirurgie du cancer du poumon fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Asie-Pacifique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché de la chirurgie du cancer du poumon.
Français Certains des principaux acteurs opérant sur le marché de la chirurgie du cancer du poumon sont AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation et entre autres.
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse de la part de marché Asie-Pacifique par rapport à la région et des fournisseurs. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 EPIDEMIOLOGY
5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY
5.2 TREATMENT RATE BY GENDER
5.3 MORTALITY BY GENDER
6 REGULATIONS OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES
7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS
7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING
7.2 RESTRAINTS
7.2.1 HIGH COST OF LUNG CANCER SURGERY
7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS
7.2.3 STRINGENT REGULATORY FRAMEWORKS
7.3 OPPORTUNITIES
7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY
7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY
7.4 CHALLENGES
7.4.1 DEARTH OF SKILLED ONCOLOGISTS
7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES
8 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SURGICAL INSTRUMENTS
8.2.1 HAND INSTRUMENTS
8.2.1.1 STAPLER
8.2.1.2 FORCEPS
8.2.1.3 ELECTRIC HOOK
8.2.1.4 RETRACTORS
8.2.1.5 CLAMPS
8.2.1.6 SCISSORS
8.2.1.7 ELEVATORS
8.2.1.8 HEMOCLIP APPLIERS
8.2.1.9 ULTRASOUND SCALPEL
8.2.1.10 RIB SHEARS
8.2.1.11 CUTTERS
8.2.1.12 NEEDLE HOLDER
8.2.1.13 TROCAR
8.2.1.14 OTHERS
8.2.2 POWERED SURGICAL EQUIPMENT
8.2.2.1 ADVANCED ENERGY INSTRUMENTS
8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS
8.2.2.1.2 OTHERS
8.2.2.2 BASIC ENERGY INSTRUMENTS
8.2.2.2.1 BIPOLAR INSTRUMENTS
8.2.2.2.2 MONOPOLAR INSTRUMENTS
8.3 MONITORING & VISUALISING SYSTEM
8.3.1 CAMERAS & VIDEO SUPPORT
8.3.2 BRONCHOSCOPES
8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
8.3.4 THORACOSCOPES
8.3.5 MEDIASTINOSCOPES
8.3.6 OTHERS
8.4 ENDOSURGICAL EQUIPMENTS
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS
8.6 OTHERS
9 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
9.1 OVERVIEW
9.2 THORACOTOMY
9.2.1 LOBECTOMY
9.2.1.1 SURGICAL INSTRUMENTS
9.2.1.2 MONITORING & VISUALISING SYSTEMS
9.2.1.3 ENDOSURGICAL EQUIPMENT
9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.1.5 OTHERS
9.2.2 SLEEVE RESECTION
9.2.2.1 SURGICAL INSTRUMENTS
9.2.2.2 MONITORING & VISUALISING SYSTEMS
9.2.2.3 ENDOSURGICAL EQUIPMENT
9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.2.5 OTHERS
9.2.3 SEGMENTECTOMY
9.2.3.1 SURGICAL INSTRUMENTS
9.2.3.2 MONITORING & VISUALISING SYSTEMS
9.2.3.3 ENDOSURGICAL EQUIPMENT
9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.3.5 OTHERS
9.2.4 PNEUMONECTOMY
9.2.4.1 SURGICAL INSTRUMENTS
9.2.4.2 MONITORING & VISUALISING SYSTEMS
9.2.4.3 ENDOSURGICAL EQUIPMENT
9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.4.5 OTHERS
9.2.5 OTHERS
9.3 MINIMALLY INVASIVE SURGERIES
9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)
9.3.1.1 SURGICAL INSTRUMENTS
9.3.1.2 MONITORING & VISUALISING SYSTEMS
9.3.1.3 ENDOSURGICAL EQUIPMENT
9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.1.5 OTHERS
9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)
9.3.2.1 SURGICAL INSTRUMENTS
9.3.2.2 MONITORING & VISUALISING SYSTEMS
9.3.2.3 ENDOSURGICAL EQUIPMENT
9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.2.5 OTHERS
10 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 MALE
10.2.1 GERIATRIC
10.2.1.1 THORACOTOMY
10.2.1.2 MINIMALLY INVASIVE SURGERIES
10.2.2 ADULTS
10.2.2.1 THORACOTOMY
10.2.2.2 MINIMALLY INVASIVE SURGERIES
10.2.3 PEDIATRIC
10.2.3.1 THORACOTOMY
10.2.3.2 MINIMALLY INVASIVE SURGERIES
10.3 FEMALE
10.3.1 GERIATRIC
10.3.1.1 THORACOTOMY
10.3.1.2 MINIMALLY INVASIVE SURGERIES
10.3.2 ADULTS
10.3.2.1 THORACOTOMY
10.3.2.2 MINIMALLY INVASIVE SURGERIES
10.3.3 PEDIATRIC
10.3.3.1 THORACOTOMY
10.3.3.2 MINIMALLY INVASIVE SURGERIES
11 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC HOSPITALS
12.2.2 PRIVATE HOSPITALS
12.3 AMBULATORY SURGICAL CENTERS
12.4 SPECIALTY CANCER CARE CENTERS
12.5 ACADEMIC AND RESEARCH LABORATORIES
12.6 OTHERS
13 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 MALAYSIA
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 JOHNSON & JOHNSON SERVICES, INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ACCURAY INCORPORATED
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 INTUITIVE SURGICAL
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FUJIFILM HOLDINGS CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AMBU A/S.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ANGIODYNAMICS
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ACKERMANN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCTPORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 FUSIONKRAFT
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 GERMED USA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 KLS MARTIN GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 KARL STORZ SE & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEDTRONICS (2021)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 OLYMPUS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCTPORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 RICHARD WOLF GMBH.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 SURGICAL HOLDINGS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SONTEC INSTRUMENTS, INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SCANLAN INTERNATIONAL
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TELEFLEX INCORPORATED
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCTPORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TROKAMED GMBH.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 WEXLER SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020
TABLE 2 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 7 ASIA PACIFIC POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 11 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 14 ASIA PACIFIC ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 ASIA PACIFIC HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 50 ASIA PACIFIC OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 ASIA-PACIFIC LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 ASIA PACIFIC LUNG CANCER SURGERYMARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC LUNG CANCER SURGERYMARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH
FIGURE 6 ASIA PACIFIC LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH
FIGURE 7 ASIA PACIFIC LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID
FIGURE 11 ASIA PACIFIC LUNG CANCER SURGERY MARKET SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE ASIA PACIFIC LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC LUNG CANCER SURGERY MARKET
FIGURE 15 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021
FIGURE 20 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021
FIGURE 24 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 28 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, 2021
FIGURE 32 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 36 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 37 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 40 ASIA PACIFIC LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.